These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34022279)

  • 1. Latrophilin-3 disruption: Effects on brain and behavior.
    Regan SL; Williams MT; Vorhees CV
    Neurosci Biobehav Rev; 2021 Aug; 127():619-629. PubMed ID: 34022279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Transient Striatal Dopamine Release and Reuptake in
    Regan SL; Cryan MT; Williams MT; Vorhees CV; Ross AE
    ACS Chem Neurosci; 2020 Apr; 11(8):1171-1177. PubMed ID: 32203648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers.
    Regan SL; Hufgard JR; Pitzer EM; Sugimoto C; Hu YC; Williams MT; Vorhees CV
    Neurobiol Dis; 2019 Oct; 130():104494. PubMed ID: 31176715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergent selective signaling impairment exposes the pathogenicity of latrophilin-3 missense variants linked to inheritable ADHD susceptibility.
    Moreno-Salinas AL; Holleran BJ; Ojeda-Muñiz EY; Correoso-Braña KG; Ribalta-Mena S; Ovando-Zambrano JC; Leduc R; Boucard AA
    Mol Psychiatry; 2022 May; 27(5):2425-2438. PubMed ID: 35393556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latrophilin-3 heterozygous versus homozygous mutations in Sprague Dawley rats: Effects on egocentric and allocentric memory and locomotor activity.
    Regan SL; Sugimoto C; Dawson HE; Williams MT; Vorhees CV
    Genes Brain Behav; 2022 Sep; 21(7):e12817. PubMed ID: 35985692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).
    Fallgatter AJ; Ehlis AC; Dresler T; Reif A; Jacob CP; Arcos-Burgos M; Muenke M; Lesch KP
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):458-68. PubMed ID: 23245769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation.
    Mortimer N; Ganster T; O'Leary A; Popp S; Freudenberg F; Reif A; Soler Artigas M; Ribasés M; Ramos-Quiroga JA; Lesch KP; Rivero O
    Neuropharmacology; 2019 Sep; 156():107557. PubMed ID: 30849401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latrophilin-2 and latrophilin-3 are redundantly essential for parallel-fiber synapse function in cerebellum.
    Zhang RS; Liakath-Ali K; Südhof TC
    Elife; 2020 Mar; 9():. PubMed ID: 32202499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of executive function in two different rat models of attention-deficit hyperactivity disorder: Spontaneously hypertensive versus Lphn3 knockout rats.
    Sable HJK; Lester DB; Potter JL; Nolen HG; Cruthird DM; Estes LM; Johnson AD; Regan SL; Williams MT; Vorhees CV
    Genes Brain Behav; 2021 Nov; 20(8):e12767. PubMed ID: 34427038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication.
    Arcos-Burgos M; Jain M; Acosta MT; Shively S; Stanescu H; Wallis D; Domené S; Vélez JI; Karkera JD; Balog J; Berg K; Kleta R; Gahl WA; Roessler E; Long R; Lie J; Pineda D; Londoño AC; Palacio JD; Arbelaez A; Lopera F; Elia J; Hakonarson H; Johansson S; Knappskog PM; Haavik J; Ribases M; Cormand B; Bayes M; Casas M; Ramos-Quiroga JA; Hervas A; Maher BS; Faraone SV; Seitz C; Freitag CM; Palmason H; Meyer J; Romanos M; Walitza S; Hemminger U; Warnke A; Romanos J; Renner T; Jacob C; Lesch KP; Swanson J; Vortmeyer A; Bailey-Wilson JE; Castellanos FX; Muenke M
    Mol Psychiatry; 2010 Nov; 15(11):1053-66. PubMed ID: 20157310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role for the ADHD risk gene latrophilin-3 in learning and memory in Lphn3 knockout rats.
    Regan SL; Pitzer EM; Hufgard JR; Sugimoto C; Williams MT; Vorhees CV
    Neurobiol Dis; 2021 Oct; 158():105456. PubMed ID: 34352385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.
    Martinez AF; Abe Y; Hong S; Molyneux K; Yarnell D; Löhr H; Driever W; Acosta MT; Arcos-Burgos M; Muenke M
    Biol Psychiatry; 2016 Dec; 80(12):943-954. PubMed ID: 27692237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study.
    Bruxel EM; Salatino-Oliveira A; Akutagava-Martins GC; Tovo-Rodrigues L; Genro JP; Zeni CP; Polanczyk GV; Chazan R; Schmitz M; Arcos-Burgos M; Rohde LA; Hutz MH
    Genes Brain Behav; 2015 Jun; 14(5):419-27. PubMed ID: 25989180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain structural and functional substrates of ADGRL3 (latrophilin 3) haplotype in attention-deficit/hyperactivity disorder.
    Moreno-Alcázar A; Ramos-Quiroga JA; Ribases M; Sánchez-Mora C; Palomar G; Bosch R; Salavert J; Fortea L; Monté-Rubio GC; Canales-Rodríguez EJ; Milham MP; Castellanos FX; Casas M; Pomarol-Clotet E; Radua J
    Sci Rep; 2021 Jan; 11(1):2373. PubMed ID: 33504901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis of Latrophilin-FLRT-UNC5 Interaction in Cell Adhesion.
    Lu YC; Nazarko OV; Sando R; Salzman GS; Li NS; Südhof TC; Araç D
    Structure; 2015 Sep; 23(9):1678-1691. PubMed ID: 26235030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development.
    O'Sullivan ML; de Wit J; Savas JN; Comoletti D; Otto-Hitt S; Yates JR; Ghosh A
    Neuron; 2012 Mar; 73(5):903-10. PubMed ID: 22405201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development.
    Lange M; Norton W; Coolen M; Chaminade M; Merker S; Proft F; Schmitt A; Vernier P; Lesch KP; Bally-Cuif L
    Mol Psychiatry; 2012 Sep; 17(9):946-54. PubMed ID: 22508465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study.
    Ribasés M; Ramos-Quiroga JA; Sánchez-Mora C; Bosch R; Richarte V; Palomar G; Gastaminza X; Bielsa A; Arcos-Burgos M; Muenke M; Castellanos FX; Cormand B; Bayés M; Casas M
    Genes Brain Behav; 2011 Mar; 10(2):149-57. PubMed ID: 21040458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADGRL3 rs6551665 as a Common Vulnerability Factor Underlying Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.
    Kappel DB; Schuch JB; Rovaris DL; da Silva BS; Müller D; Breda V; Teche SP; S Riesgo R; Schüler-Faccini L; Rohde LA; Grevet EH; Bau CHD
    Neuromolecular Med; 2019 Mar; 21(1):60-67. PubMed ID: 30652248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPHN3 gene variations and susceptibility to ADHD in Chinese Han population: a two-stage case-control association study and gene-environment interactions.
    Huang X; Zhang Q; Gu X; Hou Y; Wang M; Chen X; Wu J
    Eur Child Adolesc Psychiatry; 2019 Jun; 28(6):861-873. PubMed ID: 30406846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.